PHARMACOKINETICS OF RECOMBINANT HUMAN C1 ESTERASE INHIBITOR FOR TREATMENT OF HEREDITARY ANGIOEDEMA ATTACKS IN CHILDREN

被引：0
|
作者：
Relan, A.
Reshef, A.
Grivcheva-Panovska, V.
Kessel, A.
Kivity, S.
Klimaszewska-Rembiasz, M.
Moldovan, D.
Farkas, H.
Gutova, V.
Fritz, S.
Bellizzi, L.
Giannetti, B.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2018年 / 121卷 / 05期
关键词：
D O I：
10.1016/j.anai.2018.09.113
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P165
引用
收藏
页码：S36 / S36
页数：1
相关论文
共 50 条
  • [41] EFFICACY OF RECOMBINANT HUMAN C1 INHIBITOR FOR THE TREATMENT OF HEREDITARY ANGIOEDEMA PATIENTS WITH SEVERE ATTACKS.
    Li, H.
    Reshef, A.
    Farkas, H.
    Baker, J.
    Porebski, G.
    McNeil, D.
    Relan, A.
    Zanichelli, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 113 (05) : A5 - A5
  • [42] Recombinant human C1 inhibitor for the prophylaxis of hereditary angioedema attacks: a pilot study
    A.Reshef
    D.Moldovan
    K.Obtulowicz
    I.Leibovich
    E.Mihaly
    S.Visscher
    A.Relan
    世界最新医学信息文摘, 2014, 14 (07) : 3 - 4
  • [43] Recombinant human C1 inhibitor for the prophylaxis of hereditary angioedema attacks: a pilot study
    Reshef, A.
    Moldovan, D.
    Obtulowicz, K.
    Leibovich, I.
    Mihaly, E.
    Visscher, S.
    Relan, A.
    ALLERGY, 2013, 68 (01) : 118 - 124
  • [44] Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy
    Hakl, Roman
    Kuklinek, Pavel
    Krcmova, Irena
    Kralickova, Pavlina
    Freiberger, Tomas
    Janku, Petr
    Vlkova, Marcela
    Litzman, Jiri
    JOURNAL OF CLINICAL IMMUNOLOGY, 2018, 38 (07) : 810 - 815
  • [45] Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy
    Roman Hakl
    Pavel Kuklínek
    Irena Krčmová
    Pavlína Králíčková
    Tomáš Freiberger
    Petr Janků
    Marcela Vlková
    Jiří Litzman
    Journal of Clinical Immunology, 2018, 38 : 810 - 815
  • [46] Use of nanofiltered C1 esterase inhibitor (human) for the treatment of extremity and facial attacks in subjects with hereditary angioedema
    Riedl, M.
    Lumry, W.
    Baker, J.
    Levy, R.
    Hurewitz, D.
    White, M.
    Craig, T.
    Busse, P.
    Grant, A.
    Tillotson, G.
    Kalfus, I
    Mariano, D.
    ALLERGY, 2011, 66 : 421 - 421
  • [47] Efficacy of recombinant C1 inhibitor for laryngeal attacks of hereditary angioedema
    Riedl, M.
    Cicardi, M.
    ALLERGY, 2015, 70 : 470 - 470
  • [48] Open-label use of nanofiltered C1 esterase inhibitor (human) for the treatment of hereditary angioedema attacks
    Riedl, M.
    Zuraw, B.
    Lumry, W.
    Baker, J.
    Levy, R.
    Hurewitz, D.
    White, M.
    Craig, T.
    Busse, P.
    Bielory, L.
    Grant, A.
    Tillotson, G.
    Kalfus, I
    ALLERGY, 2011, 66 : 422 - 423
  • [49] Safety and efficacy of nanofiltered C1 esterase inhibitor (human) for the treatment of laryngeal attacks in subjects with hereditary angioedema
    Riedl, M.
    Baker, J.
    Hurewitz, D.
    Lumry, W.
    Vegh, A.
    White, M.
    Grant, A.
    Busse, P.
    Mariano, D.
    Kalfus, I
    Rubinstein, A.
    Broom, C.
    ALLERGY, 2011, 66 : 420 - 420
  • [50] Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacks
    Craig, Timothy J.
    Rojavin, Mikhail A.
    Machnig, Thomas
    Keinecke, Heinz-Otto
    Bernstein, Jonathan A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2013, 111 (03) : 211 - 215
12345